Dechra Veterinary Products
Veterinary medicines and support for veterinary professionals and animal health worldwide
Highlights
- New on EvolcAdded 2026-10-29
About Dechra Veterinary Products
Dechra develops and supplies animal health products for veterinary professionals, with products distributed worldwide.
It provides veterinary health professionals with products and support, including training through Dechra Academy.
The Finnish legal entity, Dechra Veterinary Products Oy, is headquartered in Turku and was founded in 2005.
Product: Animal health products and professional training and support for veterinary professionals.
Jobs at Dechra Veterinary Products
No open positions listed right now.
Leadership
- Jesper Nordengaard · Chief Executive OfficerSource: company website
- Ajay Gandhi · Chief Financial OfficerSource: company website
- Ian MacKellar · Chief Operating Officer and President, Global Manufacturing & Supply ChainSource: company website
- Laura Olsen · President, North America and Chief Marketing OfficerSource: company website
- Maggie Gregg · Chief People & Culture OfficerSource: company website
- Sue Egstrand · President for Europe and International, and Chief Commercial OfficerSource: company website
- Will Westwick · Chief Digital and Information OfficerSource: company website
More biotech & pharma companies
DelSiTech
Silica-based long-acting injectable drug delivery platform for pharma and biopharma partners and in-house pipelineNew on EvolcDesentum
Develops investigational allergen immunotherapies for people with pollen, food and animal allergiesNew on EvolcEpiheart
Cardiac Micrograft Therapy device company for cardiac surgery patients with heart failure, based in HelsinkiNew on EvolcEstiMates
Statistical, data management and bioinformatics services for clinical trials and life science research sponsorsNew on EvolcExperimentica
Contract research for ophthalmic drug developers: preclinical eye disease models, in vivo testing and histology servicesNew on EvolcFaron Pharmaceuticals
Clinical-stage biopharma developing immunotherapies for cancer patients, led by bexmarilimab, an anti-Clever-1 antibodyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- ASP.NET
- Google Tag Manager
- OneTrust